Clinical Trial Update: Danazol for Treatment of Cytopenias in Patients With Cirrhosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating danazol for cytopenias in patients with cirrhosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Cytopenia

Drugs mentioned

• Danazol (danazol)

Snippet

Sponsor: University of Southern California | Conditions: Cirrhosis, Liver, Cytopenia | Phase 2 | Status: RECRUITING